These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34480046)

  • 1. LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1.
    Rodriguiz RM; Nadkarni V; Means CR; Pogorelov VM; Chiu YT; Roth BL; Wetsel WC
    Sci Rep; 2021 Sep; 11(1):17690. PubMed ID: 34480046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.
    Cao C; Barros-Álvarez X; Zhang S; Kim K; Dämgen MA; Panova O; Suomivuori CM; Fay JF; Zhong X; Krumm BE; Gumpper RH; Seven AB; Robertson MJ; Krogan NJ; Hüttenhain R; Nichols DE; Dror RO; Skiniotis G; Roth BL
    Neuron; 2022 Oct; 110(19):3154-3167.e7. PubMed ID: 36087581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains.
    Ouagazzal A; Grottick AJ; Moreau J; Higgins GA
    Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT
    Poulie CBM; Pottie E; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Stove CP; Kristensen JL
    J Med Chem; 2022 Sep; 65(18):12031-12043. PubMed ID: 36099411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert⁺/⁻) mice.
    Kyzar EJ; Stewart AM; Kalueff AV
    Behav Brain Res; 2016 Jan; 296():47-52. PubMed ID: 26340513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host versus cell-dependent effects of β-arrestin 1 expression in prostate tumorigenesis.
    Adekoya TO; Smith N; Thomas AJ; Lane TS; Burnette N; Rivers EJ; Li Y; Chen XL; Richardson RM
    Carcinogenesis; 2021 May; 42(5):772-783. PubMed ID: 33710266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal Structure of an LSD-Bound Human Serotonin Receptor.
    Wacker D; Wang S; McCorvy JD; Betz RM; Venkatakrishnan AJ; Levit A; Lansu K; Schools ZL; Che T; Nichols DE; Shoichet BK; Dror RO; Roth BL
    Cell; 2017 Jan; 168(3):377-389.e12. PubMed ID: 28129538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
    de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
    ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.
    Lewis V; Bonniwell EM; Lanham JK; Ghaffari A; Sheshbaradaran H; Cao AB; Calkins MM; Bautista-Carro MA; Arsenault E; Telfer A; Taghavi-Abkuh FF; Malcolm NJ; El Sayegh F; Abizaid A; Schmid Y; Morton K; Halberstadt AL; Aguilar-Valles A; McCorvy JD
    Cell Rep; 2023 Mar; 42(3):112203. PubMed ID: 36884348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA; Harvey JA; Aloyo VJ
    Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
    Moreno JL; Holloway T; Albizu L; Sealfon SC; González-Maeso J
    Neurosci Lett; 2011 Apr; 493(3):76-9. PubMed ID: 21276828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Termination of protease-activated receptor-1 signaling by beta-arrestins is independent of receptor phosphorylation.
    Chen CH; Paing MM; Trejo J
    J Biol Chem; 2004 Mar; 279(11):10020-31. PubMed ID: 14699102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
    Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
    Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based discovery of nonhallucinogenic psychedelic analogs.
    Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
    Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.
    De Gregorio D; Popic J; Enns JP; Inserra A; Skalecka A; Markopoulos A; Posa L; Lopez-Canul M; Qianzi H; Lafferty CK; Britt JP; Comai S; Aguilar-Valles A; Sonenberg N; Gobbi G
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.